SLAGER JORAM has a total of 11 patent applications. Its first patent ever was published in 2008. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are FOUNDRY THERAPEUTICS INC, BOWS PHARMACEUTICALS AG and IMBIOTECHNOLOGIES LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Biotechnology | |
#4 | Macromolecular chemistry and polymers | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Object sterilising | |
#4 | Implantable devices | |
#5 | Peptides | |
#6 | Microorganisms | |
#7 | Polysaccharides | |
#8 | Compounding processes | |
#9 | Syringes | |
#10 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Slager Joram | 11 |
#2 | Wall John V | 2 |
#3 | Chudzik Stephen J | 1 |
#4 | Mcgonigle Joseph Schmidt | 1 |
#5 | Kurdyumov Aleksey V | 1 |
#6 | Swan Dale G | 1 |
#7 | Reed Pamela J | 1 |
#8 | New Michael D | 1 |
#9 | Anderson Aron B | 1 |
#10 | Hergenrother Robert | 1 |
Publication | Filing date | Title |
---|---|---|
US2013110222A1 | Medical devices including superhydrophobic or superoleophobic surfaces | |
US2012296274A1 | Delivery of coated hydrophobic active agent particles | |
US2012190726A1 | Functionalized polysaccharides for active agent delivery | |
US2011236454A1 | Injectable drug delivery formulation | |
US2011076337A1 | Emulsions containing arylboronic acids and medical articles made therefrom | |
US2010303878A1 | Biodegradable bioactive agent releasing matrices with particulates | |
US2010292668A1 | Method and apparatus for delivery of a therapeutic agent with an expandable medical device | |
US2009022805A1 | Polypeptide microparticles having sustained release characteristics, methods and uses |